New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment

Contributed by: Business Wire

Logo

Tags

Science

Biotechnology

Research

Pharmaceutical

Health

Diabetes

Fitness & Nutrition

Clinical Trials

Obesity

More Like This

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Airfinity launches world’s first obesity data and analytics platform

Landmark collaboration with largest pharmaceutical company

GlobeNewswire associated0

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation